Aurora Cannabis files supplement for ATM program

Executive Summary

• Aurora Cannabis Inc. has filed a prospectus supplement to establish a new At-The-Market (ATM) offering program.
• The program authorizes the company to issue and sell up to $100 million USD of common shares from treasury to the public at its discretion.
• Net proceeds are designated for strategic and accretive initiatives, specifically to expand cultivation capacity and fund mergers and acquisitions.

Key Details

• Program Capacity: Up to $100 million USD in common shares.
• Sales Mechanism: Shares will be sold via at-the-market distributions on the Nasdaq Capital Market or other U.S. marketplaces at the prevailing market price at the time of sale; privately negotiated transactions are also permitted. No sales will occur on Canadian stock exchanges.
• Sales Agreement: Dated February 4, 2026, between Aurora Cannabis Inc. and TD Securities (USA) LLC.
• Regulatory Filings: Prospectus supplement filed with securities commissions in all Canadian provinces except Quebec, and with the U.S. SEC as part of a Form F-10 registration statement under the multijurisdictional disclosure system.
• Base Prospectus Reference: Filed as a supplement to the short-form base shelf prospectus dated February 14, 2025.
• Use of Proceeds: Strategic and accretive purposes, including increased cultivation capacity and M&A activities.
• Share Structure: Common shares issued from treasury.
• Investor Resources: Copies of the prospectus supplement and base shelf prospectus are available on SEDAR+; the prospectus supplement and registration statement are available on EDGAR.